We have demonstrated that this theory of tumorigenesis with TERT promoter as the axis of genome evolution of UBC is supported by phylogenetic inference using CAPRI model based on custom heuristic optimization of cross-sectional genomic data of tumor specimens from multiple patients with UBC (75). This evidence concerns the gene TERT and neoplasm.